Announces mHealth App Development Initiative

NEW YORK, NY--(Marketwired - Nov 19, 2013) - Healthnostics, Inc. (OTC Pink: HNSS), announced that along with the launch of its revamped MedBioWeb operation, it is exploring entry into the Mobile Healthcare and Medical App Market with a focus on adapting its Hospital Quality Improvement and Risk Management System -- MedGuardian.

MedGuardian is a web-based patient care monitoring and risk management system for hospitals, providing automated data collection, reporting analysis for improving clinical treatments and reducing medical errors.

The Company's mHealth App Development initiative is initially focused on adapting MedGuardian for mobile use and development of new customized, purpose built-devices including smart phones, tablets and potentially wearable devices such as smartwatches, health and fitness trackers.

According to a recent Business Insider report, "the top 10 mobile health applications generate up to 4 million and 300,000 paid daily downloads." And last year, ABI Research indicated it expects the mHealth App market segment to reach $400 million in revenue by 2016. This emerging trend represents an enormous growth opportunity for Healthnostics by adapting its current Quality Improvement and Risk Management systems for the mobile healthcare market.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.